Design of a multicenter, randomized, double-blinded, placebo-controlled phase III trial evaluating the 9-valent human papillomavirus (HPV) vaccine to prevent persistent oral HPV infection in men living with human immunodeficiency virus: ULACNet trial 201
一项多中心、随机、双盲、安慰剂对照的III期临床试验设计，旨在评估9价人乳头瘤病毒（HPV）疫苗预防人类免疫缺陷病毒感染男性持续性口腔HPV感染的疗效：ULACNet试验201
期刊:
影响因子:
doi:10.1016/j.vaccine.2025.127447
Giuliano, Anna R; Beltrame, Anna; Villa, Luisa L; Lazcano-Ponce, Eduardo; Santana-Bagur, Jorge; Allen-Leigh, Betania; Portillo-Romero, Alejandra J; Sahasrabuddhe, Vikrant V; House, Margaret G; Brofsky, Emma; Galan de Paula, Lenice; Carvalho da Silva, Roberto; Schell, Michael J; Rathwell, Julie; Isaacs-Soriano, Kimberly; Fan, Wenyi; Mello, Caique; Ellsworth, Grant B; Wilkin, Timothy
